Evista -- Medication Information

Healthcare providers may prescribe Evista® (raloxifene hydrochloride) to prevent or treat osteoporosis in postmenopausal women. The medication can also be used to reduce the risk of breast cancer in postmenopausal women who are at high risk for the condition or who have osteoporosis.
 
This product belongs to a class of drugs called selective estrogen receptor modulators, which have both estrogen-like effects (to strengthen bones) and anti-estrogen effects (to prevent breast cancer). Evista is available by prescription only and comes in tablet form. Generally, it is taken once a day.
 
To ensure your safety with Evista, make sure your healthcare provider has up-to-date information on any other medications you are taking, including nonprescription products, as well as any allergies you may have, including to any drugs, foods, dyes, or preservatives.
 
(Click Evista for more information on this medication, including what to expect while taking it, other safety issues to discuss with your healthcare provider, and what to do in cases of overdose.)
 

Evista -- Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.